Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) EBT Margin (2021 - 2025)

Historic EBT Margin for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to 12.09%.

  • Oncology Institute's EBT Margin rose 40400.0% to 12.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.4%, marking a year-over-year increase of 42100.0%. This contributed to the annual value of 16.44% for FY2024, which is 91900.0% up from last year.
  • According to the latest figures from Q3 2025, Oncology Institute's EBT Margin is 12.09%, which was up 40400.0% from 14.31% recorded in Q2 2025.
  • Over the past 5 years, Oncology Institute's EBT Margin peaked at 35.29% during Q1 2022, and registered a low of 39.31% during Q1 2023.
  • Over the past 5 years, Oncology Institute's median EBT Margin value was 15.7% (recorded in 2024), while the average stood at 12.13%.
  • Per our database at Business Quant, Oncology Institute's EBT Margin skyrocketed by 368900bps in 2022 and then plummeted by -746000bps in 2023.
  • Over the past 5 years, Oncology Institute's EBT Margin (Quarter) stood at 24.14% in 2021, then soared by 34bps to 15.92% in 2022, then crashed by -40bps to 22.23% in 2023, then skyrocketed by 41bps to 13.15% in 2024, then increased by 8bps to 12.09% in 2025.
  • Its EBT Margin was 12.09% in Q3 2025, compared to 14.31% in Q2 2025 and 18.76% in Q1 2025.